Maternal-fetal HLA sharing and preeclampsia: Variation in effects by seminal fluid exposure in a case-control study of nulliparous women in Iowa

Journal of Reproductive Immunology

Volumn 101-102, Issue 1, 2014, Pages 111-119

  Triche, Elizabeth W ^a   Harland, Karisa K ^b,c   Field, Elizabeth H ^b,d   Rubenstein, Linda M ^c   Saftlas, Audrey F ^c  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

HLA sharing; Immunology; Maternal fetal histocompatibility; Preeclampsia; Seminal fluid

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN;

ADULT; ALLELE; ARTICLE; BODY MASS; CONTRACEPTIVE BEHAVIOR; CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; FETUS; HISTOCOMPATIBILITY; HLA SYSTEM; HLA TYPING; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; MAJOR CLINICAL STUDY; MOTHER FETUS RELATIONSHIP; PREECLAMPSIA; PRIORITY JOURNAL; SEMINAL PLASMA; SPERM; UNITED STATES; YOUNG ADULT;

HLA SHARING; IMMUNOLOGY; MATERNAL-FETAL HISTOCOMPATIBILITY; PREECLAMPSIA; SEMINAL FLUID;

ADMINISTRATION, ORAL; ADULT; CASE-CONTROL STUDIES; COITUS; ENVIRONMENTAL EXPOSURE; FEMALE; HISTOCOMPATIBILITY TESTING; HISTOCOMPATIBILITY, MATERNAL-FETAL; HLA ANTIGENS; HUMANS; IOWA; ISOANTIGENS; MALE; PARITY; PRE-ECLAMPSIA; PREGNANCY; RISK; SEMEN; SEXUAL BEHAVIOR; YOUNG ADULT;

EID: 84897611848     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2013.06.004     Document Type: Article

References (47)

1. Beer A.E., Need J.A. Immunological aspects of preeclampsia/eclampsia. Birth Defects Orig. Artic. Ser. 1985, 21(5):131-154.
2. Biggar R.J., Poulsen G., Ng J., Melbye M., Boyd H.A. HLA antigen sharing between mother and fetus as a risk factor for eclampsia and preeclampsia. Hum. Immunol. 2010, 71(3):263-267.
3. Bolis P.F., Martinetti Bianchi M., La Fianza A., Franchi M., Cuccia Belvedere M. Immunogenetic aspects of preeclampsia. Biol. Res. Pregnancy Perinatol. 1987, 8(1 1ST Half):42-45.
4. Darmochwal-Kolarz D., Kludka-Sternik M., Tabarkiewicz J., Kolarz B., Rolinski J., Leszczynska-Gorzelak B., et al. The predominance of Th17 lymphocytes and decreased number and function of Treg cells in preeclampsia. J. Reprod. Immunol. 2012, 93(2):75-81.
5. de Luca Brunori I., Battini L., Simonelli M., Clemente F., Brunori E., Mariotti M.L., et al. Increased HLA-DR homozygosity associated with pre-eclampsia. Hum. Reprod. 2000, 15(8):1807-1812.
6. Dekker G., Robillard P.-Y. Pre-eclampsia: is the immune maladaptation hypothesis still standing? An epidemiological update. J. Reprod. Immunol. 2007, 76:8-16.
7. Eras J.L., Saftlas A.F., Triche E., Hsu C.D., Risch H.A., Bracken M.B. Abortion and its effect on risk of preeclampsia and transient hypertension. Epidemiology 2000, 11(1):36-43.
8. Fujisawa S. HLA antigens-antibodies system and its association with severe toxemia of pregnancy. Nihon Sanka Fujinka Gakkai Zasshi 1985, 37(1):124-130.
9. Gill T.J. Role of the major histocompatibility complex region in reproduction, cancer, and autoimmunity. Am. J. Reprod. Immunol. 1996, 35(3):211-215.
10. Hiby S.E., Walker J.J., O'Shaughnessy K.M., Redman C.W., Carrington M., Trowsdale J., et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J. Exp. Med. 2004, 200(8):957-965.
11. Hiby S.E., Apps R., Sharkey A.M., Farrell L.E., Gardner L., Mulder A., et al. Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2. J. Clin. Invest. 2010, 120(11):4102-4110.
12. Hoff C., Peevy K., Giattina K., Spinnato J.A., Peterson R.D. Maternal-fetal HLA-DR relationships and pregnancy-induced hypertension. Obstet. Gynecol. 1992, 80(6):1007-1012.
13. Jenkins D.M., Need J.A., Scott J.S., Morris H., Pepper M. Human leucocyte antigens and mixed lymphocyte reaction in severe pre-eclampsia. Br. Med. J. 1978, 1(6112):542-544.
14. Kilpatrick D.C., Liston W.A., Jazwinska E.C., Smart G.E. Histocompatibility studies in pre-eclampsia. Tissue Antigens 1987, 29(5):232-236.
15. Kilpatrick D.C., Liston W.A., Gibson F., Livingstone J. Association between susceptibility to pre-eclampsia within families and HLA DR4. Lancet 1989, 2(8671):1063-1065.
16. Kilpatrick D.C., Gibson F., Livingston J., Liston W.A. Pre-eclampsia is associated with HLA-DR4 sharing between mother and fetus. Tissue Antigens 1990, 35(4):178-181.
17. King A., Burrows T.D., Hiby S.E., Bowen J.M., Joseph S., Verma S., et al. Surface expression of HLA-C antigen by human extravillous trophoblast. Placenta 2000, 21(4):376-387.
18. Klonoff-Cohen H.S., Savitz D.A., Cefalo R.C., McCann M.F. An epidemiologic study of contraception and preeclampsia. JAMA 1989, 262(22):3143-3147.
19. Koelman C.A., Coumans A.B.C., Nigman H.W., Doxiadis I.I.N., Dekker G.A., Claas F.H.J. Correlation between oral sex and a low incidence of preeclampsia: a role for soluble HLA in seminal fluid?. J. Reprod. Immunol. 2000, 46:155-166.
20. Li D.K., Wi S. Changing paternity and the risk of preeclampsia/eclampsia in the subsequent pregnancy. Am. J. Epidemiol. 2000, 151(1):57-62.
21. Loras B., Vetele F., El Malki A., Rollet J., Soufir J.C., Benahmed M. Seminal transforming growth factor-beta in normal and infertile men. Hum. Reprod. 1999, 14(6):1534-1539.
22. MacGillivray I. Some observations on the incidence of pre-eclampsia. J. Obstet. Gynaecol. 1958, 65(4):536-539.
23. Marti J.J., Herrmann U. Immunogestosis: a new etiologic concept of 'essential' EPH gestosis, with special consideration of the primigravid patient. Am. J. Obstet. Gynecol. 1977, 128:489-493.
24. Mostello D., Kallogjeri D., Tungsiripat R., Leet T. Recurrence of preeclampsia: effects of gestational age at delivery of the first pregnancy, body mass index, paternity, and interval between births. Am. J. Obstet. Gynecol. 2008, 199(1). 55.e51-e57.
25. National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am. J. Obstet. Gynecol. 2000, 183(1):S1-S22.
26. Ober C., Hyslop T., Elias S., Weitkamp L.R., Hauck W.W. Human leukocyte antigen matching and fetal loss: results of a 10 year prospective study. Hum. Reprod. 1998, 13(1):33-38.
27. Ohashi K., Saji F., Kato M., Wakimoto A., Tanizawa O. HLA expression on human ejaculated sperm. Am. J. Reprod. Immunol. 1990, 23(1):29-32.
28. Ooki I., Takakuwa K., Akashi M., Nonaka T., Yokoo T., Tanaka K. Studies on the compatibility of HLA-Class II alleles in patient couples with severe pre-eclampsia using PCR-RFLP methods. Am. J. Reprod. Immunol. 2008, 60(1):75-84.
29. Parham P., Guethlein L.A. Pregnancy immunogenetics: NK cell education in the womb?. J. Clin. Invest. 2010, 120(11):3801-3804.
30. Redman C.W., Sargent I.L. Immunology of pre-eclampsia. Am. J. Reprod. Immunol. 2010, 63(6):534-543.
31. Robertson S.A., Bromfield J.J., Tremellen K.P. Seminal 'priming' for protection from preeclampsia-a unifying hypothesis. J. Reprod. Immunol. 2003, 59:253-265.
32. Robertson S.A., Guerin L.R., Bromfield J.J., Branson K.M., Ahlstrom A.C., Care A.S. Seminal fluid drives expansion of the CD4+CD25+ T regulatory cell pool and induces tolerance to paternal alloantigens in mice. Biol. Reprod. 2009, 80(5):1036-1045.
33. Robertson S.A., Prins J.R., Sharkey D.J., Moldenhauer L.M. Seminal fluid and the generation of regulatory T cells for embryo implantation. Am. J. Reprod. Immunol. 2013, 69(4):315-330.
34. Robillard P.-Y., Hulsey T.C., Périanin J., Janky E., Miri E.H., Papiernik E. Association of pregnancy-induced hypertension with duration of sexual cohabitation before conception. Lancet 1994, 344(8928):973-975.
35. Saftlas A.F., Levine R.J., Klebanoff M.A., Martz K.L., Ewell M.G., Morris C.D., et al. Abortion, changed paternity, and risk of preeclampsia in nulliparous women. Am. J. Epidemiol. 2003, 157:1108-1114.
36. Saftlas A.F., Waldschmidt M., Logsden-Sackett N., Triche E., Field E. Optimizing buccal cell DNA yields in mothers and infants for human leukocyte antigen genotyping. Am. J. Epidemiol. 2004, 160:77-84.
37. Saftlas A.F., Beydoun H., Triche E. Immunogenetic determinants of preeclampsia and related pregnancy disorders: a systematic review. Obstet. Gynecol. 2005, 106(1):162-172.
38. Sahla O., Sharma V., Dada T., Nugent D., Rutherford A.J., Tomlinson A.J., et al. The influence of donated gametes on the incidence of hypertensive disorders of pregnancy. Hum. Reprod. 1999, 14:2268-2273.
39. Saito S., Sakai M., Sasaki Y., Nakashima A., Shiozaki A. Inadequate tolerance induction may induce pre-eclampsia. J. Reprod. Immunol. 2007, 76(1-2):30-39.
40. Schneider K., Knutson F., Tamsen L., Sjoberg O. HLA antigen sharing in preeclampsia. Gynecol. Obstet. Invest. 1994, 37(2):87-90.
41. Sharkey D.J., Macpherson A.M., Tremellen K.P., Mottershead D.G., Gilchrist R.B., Robertson S.A. TGF-beta mediates proinflammatory seminal fluid signaling in human cervical epithelial cells. J. Immunol. 2012, 189(2):1024-1035.
42. Sharkey D.J., Tremellen K.P., Jasper M.J., Gemzell-Danielsson K., Robertson S.A. Seminal fluid induces leukocyte recruitment and cytokine and chemokine mRNA expression in the human cervix after coitus. J. Immunol. 2012, 188(5):2445-2454.
43. Shima T., Sasaki Y., Itoh M., Nakashima A., Ishii N., Sugamura K., et al. Regulatory T cells are necessary for implantation and maintenance of early pregnancy but not late pregnancy in allogeneic mice. J. Reprod. Immunol. 2010, 85(2):121-129.
44. Wallis A.B., Saftlas A.F., Hsia J., Atrash H.K. Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987-2004. Am. J. Hypertens. 2008, 21(5):521-526.
45. Wang J.X., Knottnerus A.M., Schuit G., Norman R.J., Chan A., Dekker G.A. Surgically obtained sperm, and risk of gestational hypertension and pre-eclampsia. Lancet 2002, 359(9307):673-674.
46. Wikström A.K., Gunnarsdóttir J., Cnattingius S. The paternal role in pre-eclampsia and giving birth to a small for gestational age infant: a population-based cohort study. BMJ Open 2012, 2(4):e001178.
47. Wu Q., Zhang Z., Fan L. Association of pregnancy induced hypertension with human leucocyte antigen system. Zhonghua Fu Chan Ke Za Zhi 1997, 32(1):6-8.